Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
NCT01854827
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
NIH
Sponsor class
Conditions
Biliary Atresia
Interventions
DRUG:
Intravenous immunoglobulin (IVIG)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)